Evidence map›Paper›PMID 30885330›Full record

ReviewLung cancer (Amsterdam, Netherlands)2019

Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.

Samuel G Armato, Roslyn J Francis, Sharyn I Katz, Guntulu Ak, Isabelle Opitz, Eyjolfur Gudmundsson, Kevin G Blyth, Ashish Gupta

Open access · greenAbstract readReview
In one paragraph

Review in Lung cancer (Amsterdam, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Feature selection methods and predictive models in CT lung cancer radiomics.Journal of applied clinical medical physics · 2023
    Review
  8. New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 6 countries.

Samuel G ArmatoDepartment of Radiology, The University of Chicago, Chicago, Illinois, USA. Electronic address: s-armato@uchicago.edu.
Roslyn J FrancisDepartment of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia; Faculty of Health and Medical Sciences, University of Western Australia Medical School, Australia.
Sharyn I KatzDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Guntulu AkLung and Pleural Cancers Research and Clinical Center, Eskisehir Osmangazi University, Eskisehir, Turkey.
Isabelle OpitzDivision of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Eyjolfur GudmundssonDepartment of Radiology, The University of Chicago, Chicago, Illinois, USA.
Kevin G BlythGlasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; Institute of Infection, Immunity & Inflammation, University of Glasgow, UK.
Ashish GuptaDepartment of Radiology, The Ottawa Hospital, Ottawa, Ontario, Canada.
University of Chicago · USEskişehir Osmangazi University · TROttawa Hospital · CAQueen Elizabeth University Hospital · GBThe University of Western Australia · AUUniversity Hospital of Zurich · CHUniversity of Pennsylvania · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
High-Performance Computer Cluster for Image AnalysisS10RR021039 · NCRR · UNIVERSITY OF CHICAGO · PI NISHIKAWA, ROBERT M · 2007 to 2007
$230k
NCI NIH HHS P30 CA014599NCRR NIH HHS S10 RR021039
6 · The paper itself

Abstract

Mesothelioma patients rely on the information their clinical team obtains from medical imaging. Whether x-ray-based computed tomography (CT) or magnetic resonance imaging (MRI) based on local magnetic fields within a patient's tissues, different modalities generate images with uniquely different appearances and information content due to the physical differences of the image-acquisition process. Researchers are developing sophisticated ways to extract a greater amount of the information contained within these images. This paper summarizes the imaging-based research presented orally at the 2018 International Conference of the International Mesothelioma Interest Group (iMig) in Ottawa, Ontario, Canada, held May 2-5, 2018. Presented topics included advances in the imaging of preclinical mesothelioma models to inform clinical therapeutic strategies, optimization of the time delay between contrast administration and image acquisition for maximized enhancement of mesothelioma tumor on CT, an investigation of image-based criteria for clinical tumor and nodal staging of mesothelioma by contrast-enhanced CT, an investigation of methods for the extraction of mesothelioma tumor volume from MRI and the association of volume with patient survival, the use of deep learning for mesothelioma tumor segmentation in CT, and an evaluation of CT-based radiomics for the prognosis of mesothelioma patient survival.

Indexed as

Congresses as TopicDiagnostic ImagingHumansInternational CooperationMagnetic Resonance ImagingMesotheliomaPhantoms, ImagingPleuraPleural NeoplasmsPrognosisPublic OpinionTomography, X-Ray ComputedClinical stagingDeep learningDynamic contrast-enhanced CTPatient outcomesPreclinical imagingRadiomicsTumor segmentationTumor volume

Identifiers

PMID30885330
PMCPMC6548565
OpenAlexW2917122354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.